OssDsign® Spine Registry Study ("Propel")

Launched by OSSDSIGN · Apr 8, 2022

Keywords

ClinConnect Summary

The OssDsign® Spine Registry Study, also known as "Propel," is a clinical trial that aims to collect information about how well a specific type of bone graft substitute works for patients undergoing spine fusion surgery. This study focuses on patients with conditions like degenerative disc disease and spinal stenosis. The main goal is to understand the real-world effectiveness of OssDsign® bone grafts in helping patients heal after their surgery.

To participate in this study, patients need to be at least 21 years old and have been recommended for spinal fusion surgery where the OssDsign® bone graft is considered suitable by their surgeon. Participants should be able to follow the study's guidelines, which include attending follow-up appointments and completing necessary paperwork for up to two years after their surgery. This study is still enrolling participants, so it's a great opportunity for those who qualify to contribute to important research while receiving care for their spine condition.

Gender

ALL

Eligibility criteria

• • The patient has been diagnosed as a candidate for spinal fusion surgery for which the surgeon has decided an OssDsign® bone graft is appropriate.
• • The patient is ≥21 years old.
• • The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
• • The patient is willing and able to participate in post- operative clinical and radiographic follow up evaluations for 2 years.
• Exclusion Criteria:
• • Patients not meeting all of the inclusion criteria